Valspring Capital Successfully Closes Fund I Above Target at $255 Million

– Valspring Capital, a healthcare-focused growth equity firm, has closed its debut fund, Valspring Capital Fund I, at $255 million, exceeding its target.

– The firm was founded by Yumin Choi, Amy Sievert and Amanda Zajac in 2022. A team spun off from Bain Capital Ventures focusing on growth-stage healthcare companies in North America.

– Investment areas include information technology, technology-enabled services, and healthcare services.
– The fund received strong interest from a diverse group of limited partners (LPs), including endowments, pensions, financial institutions, funds of funds, and private wealth firms.

Yumin Choi, Managing Partner, stated: “We are thrilled to announce the close of our debut fund and proud to close above target amid a challenging environment for growth equity.”

– Two investments were completed during fundraising: HealthJoy and Phoenix.

Monument Group acted as the exclusive placement agent, and Ropes & Gray LLP served as general counsel.

Bart Molloy, Partner at Monument Group: “Monument Group was honored to partner with Valspring on their successful inaugural fundraise.”

You may also like these